Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

10x Genomics (TXG) Interest Expenses (2018 - 2025)

10x Genomics' Interest Expenses history spans 8 years, with the latest figure at -$3000.0 for Q3 2025.

  • On a quarterly basis, Interest Expenses fell 250.0% to -$3000.0 in Q3 2025 year-over-year; TTM through Jun 2025 was $5000.0, a 54.55% decrease, with the full-year FY2024 number at $4000.0, down 87.88% from a year prior.
  • Interest Expenses hit -$3000.0 in Q3 2025 for 10x Genomics, down from $3000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for TXG hit a ceiling of $221000.0 in Q1 2021 and a floor of -$3000.0 in Q3 2025.
  • Historically, Interest Expenses has averaged $81117.6 across 5 years, with a median of $19000.0 in 2023.
  • The widest YoY moves for Interest Expenses: up 200.0% in 2025, down 250.0% in 2025.
  • Tracing TXG's Interest Expenses over 5 years: stood at $217000.0 in 2021, then plummeted by 42.4% to $125000.0 in 2022, then crashed by 93.6% to $8000.0 in 2023, then crashed by 75.0% to $2000.0 in 2024, then tumbled by 250.0% to -$3000.0 in 2025.
  • Business Quant data shows Interest Expenses for TXG at -$3000.0 in Q3 2025, $3000.0 in Q2 2025, and $2000.0 in Q3 2024.